Clinical Trials Logo

Filter by:
NCT ID: NCT06430788 Recruiting - Aplastic Anemia Clinical Trials

A Study of Emapalumab for Pediatric Aplastic Anemia

Start date: May 21, 2024
Phase: Phase 2
Study type: Interventional

The purpose of this study is to find out whether upfront emapalumab treatment can help in sAA (Aplastic Anemia) treatment planning and increase the effectiveness of standard treatment options.

NCT ID: NCT06430684 Not yet recruiting - Clinical trials for Chronic Kidney Diseases

Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease

SGLT2I-IN-KIDS
Start date: May 2024
Phase: Early Phase 1
Study type: Interventional

The goal of this study is to learn if a clinical trial of sodium-glucose co-transporter 2 inhibitors (SGLT2i) is possible in youth with chronic kidney disease (CKD). The investigators also plan to explore whether treatment with SGLT2i (Empagliflozin) helps improve risk factors for worsening kidney and heart disease. The main questions are: 1. Is enrolling 40 youth with CKD into a clinical trial of empagliflozin feasible (ie achievable)? 2. Does taking empagliflozin for 3 months result in positive changes in blood, urine, and heart function tests? Participants will be randomly selected (like flipping a coin) to either receive empagliflozin or not start treatment with empagliflozin and remain on their usual care. Study Procedures Include - For participants randomly selected for treatment, take empagliflozin once daily for 3 months - Phone calls with researchers every 2 weeks for check-ins - For participants taking empagliflozin, clinic visits 4 and 8 weeks after starting for check-ups and tests - All study participants will have clinic visits at the beginning and end (3 months) where researchers will collect information about their health and perform tests

NCT ID: NCT06430632 Recruiting - Stroke Clinical Trials

Early Robotic Gait Training After Stroke

ERA Stroke
Start date: March 1, 2024
Phase: N/A
Study type: Interventional

The ERA Stroke project will compare the effects of robotic gait training (RGT) and usual care (UC) gait training in patients in the subacute phase of stroke recovery undergoing inpatient rehabilitation at the Baylor Scott & White Institute for Rehabilitation (BSWIR).

NCT ID: NCT06430541 Not yet recruiting - Breast Cancer Clinical Trials

A Phase 1b Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence

Start date: December 2024
Phase: Phase 1
Study type: Interventional

The goal of this clinical trial is to test whether psilocybin along with therapy in women with early breast cancer and ovarian cancer in remission can improve their fear of recurrence. The main question[s] it aims to answer [is/are]: Does psilocybin assisted therapy improve fear of cancer recurrence? Does psilocybin assisted therapy improve anxiety, depression, and quality of life? Participants will complete a series of survey measures, participate in preparatory therapy. After prep therapy is complete, they will receive a moderately high dose of psilocybin in a monitored and supportive environment. After the dosing day, they will complete 4 sessions of integrative therapy and complete survey measures.

NCT ID: NCT06430528 Recruiting - Clinical trials for Adrenal Insufficiency

A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement

Start date: May 2024
Phase:
Study type: Observational

The major goal of this study is to determine the incidence of adrenal insufficiency in patients with endogenous Cushing syndrome receiving osilodrostat treatment combined with a replacement of glucocorticoid (block-and-replace approach). The investigators are also evaluating new biomarker steroids to reflect adequate osilodrostat dosing, the durability and safety, and clinical improvement during treatment.

NCT ID: NCT06430346 Recruiting - Esophageal Cancer Clinical Trials

Exercise Prehabilitation for Locoregional Esophageal Cancer

Start date: May 21, 2024
Phase: N/A
Study type: Interventional

The purpose of the study is to examine the feasibility and acceptability of exercise "prehabilitation" for patients preparing for esophageal cancer resection (removal).

NCT ID: NCT06430333 Not yet recruiting - Depression Clinical Trials

Sleep to Reduce Incident Depression Effectively in Peripartum

STRIDE P
Start date: October 1, 2025
Phase: N/A
Study type: Interventional

Perinatal depression (PND) is the most common complication in pregnancy and postpartum, which increases risk for adverse perinatal outcomes such as preterm birth, maternal suicidal thoughts, and impaired mother-infant bonding. Insomnia often precedes PND cases and may serve as an entry point for interventions preventing PND. The proposed project is a large-scale clinical trial to test the effectiveness of a mindfulness-based sleep program designed for pregnant women to improve sleep and alleviate cognitive arousal to reduce risk for PND across pregnancy and postpartum.

NCT ID: NCT06430320 Enrolling by invitation - Uterine Fibroid Clinical Trials

Ascertaining Longterm Outcomes of Fibroid Treatments

ALOFT
Start date: May 20, 2024
Phase:
Study type: Observational

The goal of the ALOFT study is to understand the health of women in the 12 years following a uterine fibroid (UF) treatment. ALOFT is a multi-center, prospective, observational cohort study of approximately 700 women who have undergone uterine-sparing treatment procedures for UF and previously participated in the longitudinal studies COMPARE-UF (NCT02260752) or ULTRA (NCT02100904). The primary uterine sparing treatment procedures undergone by study participants are myomectomy, endometrial ablation (EA), uterine artery embolization (UAE) and laparoscopic radiofrequency ablation (RFA). A smaller number of women may be studied who underwent focused ultrasound, intrauterine device (IUD), and medical management. Two follow-up study contacts with COMPARE-UF and ULTRA participants will occur to assess changes in UF symptoms and treatment failure which is defined as the need for another UF treatment procedure. Questionnaires will be used to collect data on patient-reported characteristics and outcomes and quality of life. The study's analyses will focus on comparisons of primary and secondary outcomes among women.

NCT ID: NCT06430268 Recruiting - Peri-Implantitis Clinical Trials

Efficacy of Non-surgical and Surgical Surface Decontamination Methods on Peri-implantitis-affected Implants

Start date: May 21, 2024
Phase: N/A
Study type: Interventional

This study will compare 2 methods to clean contaminated implant surfaces: air-polishing device versus titanium curette. Both of these methods will be used in the non-surgical and surgical setting, followed by implant removal. Then, in-vitro analysis to assess the efficacy of surface decontamination will be performed.

NCT ID: NCT06430164 Recruiting - Gait Clinical Trials

AB Gait Estim Neurophysiology

Start date: February 12, 2024
Phase: N/A
Study type: Interventional

This study is being done to answer the question: What are the effects of electrical stimulation and stepping practice on connections between the brain and muscles? The long-term goal of this project is to develop novel, effective, and personalized rehabilitation protocols founded on an understanding of neurobiological mechanisms that combine electrical stimulation with gait training to improve gait performance in older adults and stroke survivors. The rationale of this project is to explore and generate preliminary data regarding how electrical stimulation-based strategies modulate cortical and spinal circuits in able-bodied individuals. The researchers will evaluate the effects of short treadmill walking bouts or single gait training sessions with and without electrical stimulation on somatosensory, spinal-reflex, corticospinal circuit neurophysiology, and/or gait performance. The study will provide important preliminary and normative data that can explain how brain circuits change with stimulation or stepping practice and inform future rehabilitation studies on patients. The study population is able-bodied individuals.